Skip to main content
. 2022 Dec 1;22:367. doi: 10.1186/s12871-022-01918-9

Table 3.

Post-operative complications and clinical outcomes of patients who underwent esophagectomy for cancer

ETI (n = 21) Control (n = 21) p-value
Postoperative complications
 Pulmonarya 17(81.0%) 4(19.0%) 0.000
 Cardiaca 12(57.1%) 8(38.1%) 0.217
 Anastomotic leaka 9(42.9%) 2(9.5%) 0.014
 Hepatica 9(42.9%) 6(28.6%) 0.334
 Renala 1(4.8%) 0(0%)
 Thromboembolica 7(33.3%) 2(9.5%) 0.133
 Electrolyte disordera 17(81.0%) 7(33.3%) 0.002
 Postoperative bleedinga 2(9.5%) 0(0%) 0.469
 Sepsisa 3(14.3%) 0(0%) 0.231
 Shocka 5(23.8%) 0(0%) 0.057
Clinical outcomes
 Reoperationsa 12(57.1%) 1(4.8%) 0.000
 PLOS (days) b 38.17 ± 21.41 17.67 ± 9.41 0.000
 Charge (*103 RMB) b 198.55 ± 15.94 88.75 ± 11.85 0.000
 In-hospital Mortalitya 4(19.0%) 0(0%)
 3-year OSa 10(47.6%) 18(85.7%) 0.018

Data are presented as number (percentage), or ratio or mean ± standard deviation

ETI Emergent endotracheal intubation, PLOS Post-operative length of stay, OS Overall survival

aChi-square

bTwo-tailed Student’s t test